{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T19:00:26Z","timestamp":1780254026432,"version":"3.54.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,31]]},"DOI":"10.7759\/cureus.109992","type":"journal-article","created":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T18:05:02Z","timestamp":1780250702000},"source":"Crossref","is-referenced-by-count":0,"title":["When Fatigue Was Vasculitis: A Case of Limited PR3 ANCA-Positive Granulomatosis With Polyangiitis"],"prefix":"10.7759","author":[{"given":"Montasir","family":"Elmobark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wisam","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich B","year":"2024","unstructured":"Hellmich B, Sanchez-Alamo B, Schirmer JH, et al.. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. 2024, 83:30-47. 10.1136\/ard-2022-223764","journal-title":"Ann Rheum Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/art.41773","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"73","author":"Chung SA","year":"2021","unstructured":"Chung SA, Langford CA, Maz M, et al.. 2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol. 2021, 73:1366-1383. 10.1002\/art.41773","journal-title":"Arthritis Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2005.12.003","article-title":"Wegener\u2019s granulomatosis: ophthalmic manifestations and management","volume":"35","author":"Pakrou N","year":"2006","unstructured":"Pakrou N, Selva D, Leibovitch I. Wegener\u2019s granulomatosis: ophthalmic manifestations and management. Semin Arthritis Rheum. 2006, 35:284-292. 10.1016\/j.semarthrit.2005.12.003","journal-title":"Semin Arthritis Rheum"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000748","article-title":"Pituitary involvement in granulomatosis with polyangiitis: report of 9 patients and review of the literature","volume":"94","author":"De Parisot A","year":"2015","unstructured":"De Parisot A, Pu\u00e9chal X, Langrand C, et al.. Pituitary involvement in granulomatosis with polyangiitis: report of 9 patients and review of the literature. Medicine (Baltimore). 2015, 94:e748. 10.1097\/MD.0000000000000748","journal-title":"Medicine (Baltimore)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1962","article-title":"Pituitary dysfunction in granulomatosis with polyangiitis: the Mayo Clinic experience","volume":"99","author":"Kapoor E","year":"2014","unstructured":"Kapoor E, Cartin-Ceba R, Specks U, Leavitt J, Erickson B, Erickson D. Pituitary dysfunction in granulomatosis with polyangiitis: the Mayo Clinic experience. J Clin Endocrinol Metab. 2014, 99:3988-3994. 10.1210\/jc.2014-1962","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(83)34574-7","article-title":"Ocular complications of Wegener\u2019s granulomatosis","volume":"90","author":"Bullen CL","year":"1983","unstructured":"Bullen CL, Liesegang TJ, McDonald TJ, DeRemee RA. Ocular complications of Wegener\u2019s granulomatosis. Ophthalmology. 1983, 90:279-290. 10.1016\/s0161-6420(83)34574-7","journal-title":"Ophthalmology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf240","article-title":"The 2025 British Society for Rheumatology management recommendations for ANCA-associated vasculitis","volume":"64","author":"Biddle K","year":"2025","unstructured":"Biddle K, Jade J, Wilson-Morkeh H, et al.. The 2025 British Society for Rheumatology management recommendations for ANCA-associated vasculitis. Rheumatology (Oxford). 2025, 64:4470-4494. 10.1093\/rheumatology\/keaf240","journal-title":"Rheumatology (Oxford)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/495831-when-fatigue-was-vasculitis-a-case-of-limited-pr3-anca-positive-granulomatosis-with-polyangiitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T18:05:03Z","timestamp":1780250703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/495831-when-fatigue-was-vasculitis-a-case-of-limited-pr3-anca-positive-granulomatosis-with-polyangiitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,31]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.109992","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,31]]}}}